Promoter variant in the catalase gene is associated with vitiligo in chinese people

Journal of Investigative Dermatology

Volumn 130, Issue 11, 2010, Pages 2647-2653

  Liu, Ling ^a   Li, Chunying ^a   Gao, Jian ^a   Li, Kai ^a   Zhang, Rui ^b   Wang, Gang ^a   Li, Chenxin ^a   Gao, Tianwen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CATALASE; CYSTEINE; THREONINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

EID: 77957964532     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.192     Document Type: Article

References (39)

1. Arican O, Kurutas EB (2008) Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerol Alp Panonica Adriat 17:12-6
2. 2-induced cell death in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 290: L978-86
3. Boisseau-Garsaud AM, Garsaud P, Lejoly-Boisseau H et al. (2002) Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo. Int J Dermatol 41:640-2
4. Brennan P (2002) Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 23:381-7
5. Casp CB, She JX, McCormack WT (2002) Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 15:62-6
6. Castanet J, Ortonne JP (1997) Pathophysiology of vitiligo. Clin Dermatol 15:845-51
7. Drysdale CM, McGraw DW, Stack CB et al. (2000) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 97:10483-8
8. Forsberg L, Lyrenas L, de Faire U et al. (2001) A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 30:500-5
9. 2 at physiological concentrations modulates Leydig cell function inducing oxidative stress and apoptosis. Apoptosis 11:39-46
10. Gavalas NG, Akhtar S, Gawkrodger DJ et al. (2006) Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem Biophys Res Commun 345:1586-91
11. Góth L, Eaton JW (2000) Hereditary catalase deficiencies and increased risk of diabetes. Lancet 356:1820-1
12. Góth L, Rass P, Páy A (2004) Catalase enzyme mutations and their association with diseases. Mol Diagn 8:141-9
13. Góth L, Rass P, Madarasi I (2001) A novel catalase mutation detected by polymerase chain reaction-single strand conformation polymorphism, nucleotide sequencing, and Western blot analyses is responsible for the type C of Hungarian acatalasemia. Electrophoresis 22:49-51
14. 0 of the catalase gene in Hungarian acatalasemia and hypocatalasemia. Electrophoresis 18:1105-8
15. Handa S, Kaur I (1999) Vitiligo: clinical findings in 1436 patients. J Dermatol 26:653-7
16. 2 stress. J Invest Dermatol 122:307-13
17. Hazneci E, Karabulut AB, Ozturk C et al. (2005) A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients. IntJ Dermatol 44:636-40
18. Herane MI (2003) Vitiligo and leukoderma in children. Clin Dermatol 21:283-95
19. Ines D, Sonia B, Riadh BM et al. (2006) A comparative study of oxidant-antioxidant status in stable and active vitiligo patients. Arch Dermatol Res 298:147-52
20. Jiang Z, Akey JM, Shi J et al. (2001) A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet 109:95-8
21. Jimbow K, Chen H, Park JS et al. (2001) Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 144:55-65
22. Kocaturk PA, Kavas GO, Cebeci SA (2004) Endothelin-1 induced alterations in oxidative-nitrosative stress markers. Saudi Med J 25:1835-8
23. Kosmidou M, Hatzitolios AI, Molyva D et al. (2009) An association study between catalase \-262C>T gene polymorphism, sodium-lithium countertransport activity, insulin resistance, blood lipid parameters and their response to atorvastatin, in Greek dyslipidaemic patients and normolipidaemic controls. Free Radic Res 43:385-9
24. Liu L, Li C, Gao J et al. (2009) Genetic polymorphisms of glutathione S-transferase and risk of vitiligo in the Chinese population. J Invest Dermatol 129:2646-52
25. Lu T, Gao T, Wang A et al. (2007) Vitiligo prevalence study in Shaanxi Province, China. IntJ Dermatol 46:47-51
26. Maresca V, Flori E, Briganti S et al. (2007) Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress. Pigment Cell Melanoma Res 21:200-5
27. Park HH, Ha E, Uhm YK et al. (2006) Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population. Exp Dermatol 15:377-80
28. Passi S, Grandinetti M, Maggio F et al. (1998) Epidermal oxidative stress in vitiligo. Pigment Cell Res 11:81-5
29. Rezvani HR, Mazurier F, Cario-Andre M et al. (2006) Protective effects of catalase overexpression on UVB-induced apoptosis in normal human keratinocytes. J Biol Chem 281:17999-8007
30. Rokos H, Beazley WD, Schallreuter KU (2002) Oxidative stress in vitiligo: photo-oxidation of pterins produces H(2)O(2) and pterin-6-carboxylic acid. Biochem Biophys Res Commun 292:805-11
31. Schallreuter KU (1999) Successful treatment of oxidative stress in vitiligo. Skin Pharmacol Appl Skin Physiol 12:132-8
32. 2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 315:502-8
33. Schallreuter KU, Wood JM, Berger J (1991) Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 97:1081-5
34. Shaffrali F, Gawkrodger D (2000) Management of vitiligo. Clin Exp Dermatol 25:575-9
35. Sies H (1991) Role of reactive oxygen species in biological processes. Klin Wochenschr 69:965-8
36. Spencer JD, Gibbons NC, Rokos H et al. (2007) Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 127:411-20
37. Takemoto K, Tanaka M, Iwata H et al. (2009) Low catalase activity in blood is associated with the diabetes caused by alloxan. Clin Chim Acta 407:43-6
38. Wood JM, Gibbons NC, Chavan B et al. (2008) Computer simulation of heterogeneous single nucleotide polymorphisms in the catalase gene indicates structural changes in the enzyme active site, NADPH-binding and tetramerization domains: a genetic predisposition for an altered catalase in patients with vitiligo? Exp Dermatol 17:366-71
39. Yildirim M, Baysal V, Inaloz HS et al. (2003) The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 30:104-8